Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry v3.6.5 has been added to the study record. The Plain Language Summary and the prior revision entry v3.6.4 have been removed, affecting lay reader readability and the revision history.
    Difference
    0.1%
    Check dated 2026-08-08T14:47:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.6.4' was added, replacing the previous 'Revision: v3.6.3', indicating a small backend update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-07-25T08:28:16.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. It reflects a small backend update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-03T22:10:55.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor page revision. This update appears to be a label-only change and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:22.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision version (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-12T13:27:13.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a new internal revision was applied. This update does not modify visible study information.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.